These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis. Pavan M; Aiyangar A; Chaudhari A; Rajputh P; Ranganath R; Babulal SA Iran J Kidney Dis; 2010 Apr; 4(2):162-3. PubMed ID: 20404430 [TBL] [Abstract][Full Text] [Related]
3. Continuous ambulatory peritoneal dialysis in scleroderma. Jones B; Trevillian P; Lake N Nephron; 1990; 54(1):107-8. PubMed ID: 2296338 [No Abstract] [Full Text] [Related]
4. CAPD and systemic diseases. Cantaluppi A Clin Nephrol; 1988; 30 Suppl 1():S8-12. PubMed ID: 3052963 [TBL] [Abstract][Full Text] [Related]
5. Continuous ambulatory peritoneal dialysis in a patient with scleroderma. Khaira A; Rathi OP; Gupta S; Agarwal SK Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):130-1. PubMed ID: 19112233 [No Abstract] [Full Text] [Related]
6. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease. Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268 [TBL] [Abstract][Full Text] [Related]
7. Preliminary experience with continuous ambulatory peritoneal dialysis. Rahman M; Haq SA; Haq A Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
9. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Balasubramanian G; McKitty K; Fan SL Nephrol Dial Transplant; 2011 May; 26(5):1702-8. PubMed ID: 20921296 [TBL] [Abstract][Full Text] [Related]
13. Is peritoneal dialysis the preferred modality in the diabetic patient? Kraus MA; Hamburger RJ Adv Perit Dial; 1996; 12():89-92. PubMed ID: 8865879 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Yang F; Lau T; Luo N Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750 [TBL] [Abstract][Full Text] [Related]
15. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD. Sawin DA; Himmele R; Diaz-Buxo JA Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227 [TBL] [Abstract][Full Text] [Related]
16. [Continuous ambulatory peritoneal dialysis, CAPD. 18-month experience with a new form of treatment of chronic renal failure]. Ekelund B; Jørgensen JI Ugeskr Laeger; 1982 Sep; 144(38):2776-9. PubMed ID: 7157503 [No Abstract] [Full Text] [Related]
17. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414 [TBL] [Abstract][Full Text] [Related]
18. [Peritoneal dialysis in patients with polycystic kidneys]. Pavlović NB; Stojacnov S; Ljubenović S; Krivokapić R Srp Arh Celok Lek; 1996; 124 Suppl 1():157-8. PubMed ID: 9102888 [TBL] [Abstract][Full Text] [Related]
19. Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease. Browning MJ; Banks RA; Harrison P; Tribe CR; Fraley CT; Zachary G; Mackenzie C J R Soc Med; 1984 Mar; 77(3):189-92. PubMed ID: 6699861 [TBL] [Abstract][Full Text] [Related]